Lobbying

Varian Medical Systems's latest lobbying report covers Q3 2023, at $260K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.

Varian Medical Systems

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Varian Medical Systems lobbying by quarter
Varian Medical Systems lobbying by quarter
QuarterAmountReports
Q4 2022$450K3
Q1 2023$240K1
Q2 2023$210K1
Q3 2023$260K1
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$393.3K · 4 reports
  • Medical research and clinical labs$393.3K · 4 reports
  • Trade$98.3K · 4 reports
  • Medicare and Medicaid$98.3K · 3 reports
  • Education$73.3K · 2 reports
  • Labor, antitrust and workplace$73.3K · 2 reports
  • Budget and appropriations$30K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Food & Drug Administration (FDA)3 reports

Firms it paid

Firm
In-houseVarian Medical Systems$1.1M4 quarters
Capitol Counsel$50K1 quarters
Ballard Partners$01 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
23/10/20for Q3 2023In-house$260K
23/07/20for Q2 2023In-house$210K
23/07/20for Q4 2022In-house$400K
23/04/18for Q4 2022Capitol Counsel$50K
23/04/17for Q1 2023In-house$240K
23/01/20for Q4 2022In-house$400K
23/01/20for Q4 2022Ballard PartnersUnder $5,000
23/01/19for Q4 2022Capitol Counsel$50K